Postdoctoral Grant
Improved Detection of Breast Cancer During Imaging and Surgery with a New Contrast Agent
Awarded in 2025
The project, Improved Detection of Breast Cancer During Imaging and Surgery with a New Contrast Agent, led by research associate S. A. Amali S. Subasinghe, PhD, aims to improve the detection and surgical removal of breast cancer using a new contrast agent that becomes visible only within tumor tissue. The agent is activated by the enzyme cPLA2α, which is more active in cancer cells than in healthy cells, causing the compound to form a natural black pigment that highlights tumors. The study will test the contrast agent using optoacoustic imaging to detect tumors deep within the body and evaluate its ability to help surgeons visually identify tumor tissue during operations. Mark (Marty) Pagel, PhD, professor in the Department of Medical Physics, serves as the supervising mentor.